---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-082331"
form_type: "8-K"
ticker: "BTMD"
cik: "0001819253"
company_name: "biote Corp."
filed_at: "2023-03-28T23:59:59+00:00"
generated_at: "2026-06-17T13:16:48.034171+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Biote reports record FY2022 revenue $165M, Q4 adj EBITDA up 40%; guides FY2023 rev $190-200M

## Summary
- Q4 revenue $44.5M (+18.5%), net income $12.8M, diluted EPS $0.18; adjusted EBITDA $13.1M (+40%).
- FY2022 revenue $165.0M (+18.3%), net income $1.3M, diluted EPS loss ($0.12); adjusted EBITDA $50.1M (+24.6%).
- 2023 guidance: revenue $190-200M, adjusted EBITDA $56-60M; expects stronger H2 performance.
- Completed secondary offering in Jan 2023 to increase trading liquidity and broaden institutional ownership.

## SEC filing metadata
- accession: 0001193125-23-082331
- form_type: 8-K
- ticker: BTMD
- cik: 0001819253
- company_name: biote Corp.
- filed_at: 2023-03-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819253/000119312523082331/0001193125-23-082331-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819253/000119312523082331/d490354d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-082331
- JSON: https://secwatch.observer/filing/0001193125-23-082331.json
- Plain text: https://secwatch.observer/filing/0001193125-23-082331.txt

## Key facts
- Earnings Releases
  biote Corp. reported the fourth quarter ended December 31, 2022 results: revenue $44.5 million, net income $12.8 million, EPS $0.18.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: $44.5 million
  - Net income: $12.8 million
  - EPS: $0.18
  - Result: reported results
  source text: Fourth Quarter Highlights, year over year : • Revenue of $44.5 million, an 18.5% increase. • Net income of $12.8 million and fully diluted GAAP earnings per share of $0.18.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819253/000119312523082331/0001193125-23-082331-index.htm
- Earnings Releases
  biote Corp. reported 2023 results: revenue $190-200 million. Guidance initiated.
  - Period: 2023
  - Revenue: $190-200 million
  - Guidance: initiated
  - Result: guidance update
  source text: Expect 2023 Revenue of $190-200 million and Adjusted EBITDA of $56-60 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819253/000119312523082331/0001193125-23-082331-index.htm
- Earnings Releases
  biote Corp. reported the fiscal year ended December 31, 2022 results: revenue $165.0 million, net income $1.3 million, EPS $(0.12).
  - Period: the fiscal year ended December 31, 2022
  - Revenue: $165.0 million
  - Net income: $1.3 million
  - EPS: $(0.12)
  - Result: reported results
  source text: Full Year 2022 Highlights, year over year: • Revenue of $165.0 million, an 18.3% increase. • Net income of $1.3 million and fully diluted GAAP loss per share of $(0.12).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819253/000119312523082331/0001193125-23-082331-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.